Literature DB >> 23089461

Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma.

Nadia Lago Costa1, Marize Campos Valadares, Pedro Paulo Chaves Souza, Elismauro Francisco Mendonça, José Carlos Oliveira, Tarcíla Aparecida Silva, Aline Carvalho Batista.   

Abstract

OBJECTIVE: To evaluate and characterize macrophage populations (M1/M2) in the tumor microenvironment of oral cavity squamous cell carcinoma (OCSCC). The relationship between macrophages and clinicopathological factors, such as survival data, lymph node metastasis, tumoral proliferation, and WHO histological grading are also analyzed.
MATERIALS AND METHODS: The samples consisted of surgically excised specimens from patients with non-metastatic and metastatic OCSCC and normal oral mucosa (control). Immunohistochemistry, flow cytometry, and qRT-PCR were used to evaluate macrophage populations and the expression of pro- (IL-12, IL-23, and INF-γ) and anti-inflammatory (IL-10 and TGF-β) cytokines. The level required for statistical significance was defined as p<0.05.
RESULTS: The data showed a predominance of M2 phenotype (high percentage of IL-10(+)TGF-β(+)) macrophages in the tumor microenvironment of OCSCC. A higher percentage of macrophages expressing TGF-β was seen in the OCSCC group when compared with healthy individuals. The assessment of mRNA expression also presented a greater expression of anti-inflammatory cytokines TGFβ and IL10 in OCSCC when compared with the control group. The percentage of macrophages, demonstrated by immunohistochemistry, was significantly higher in the metastatic OCSCC group than in the non-metastatic and control groups. The log-rank test also showed that the mean survival time for patients with high levels of macrophages was less (44 months) when compared with patients with a low percentage of such cells (93 months).
CONCLUSION: A predominance of the M2 phenotype in the tumor microenvironment of OCSCC could contribute to local immunosuppression, via TGF-β production, and consequently greater lymph node involvement and reduced patient survival time.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23089461     DOI: 10.1016/j.oraloncology.2012.09.012

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  51 in total

Review 1.  Immune Evasion by Head and Neck Cancer: Foundations for Combination Therapy.

Authors:  Joshua D Horton; Hannah M Knochelmann; Terry A Day; Chrystal M Paulos; David M Neskey
Journal:  Trends Cancer       Date:  2019-03-20

2.  Microlocalization of CD68+ tumor-associated macrophages in tumor stroma correlated with poor clinical outcomes in oral squamous cell carcinoma patients.

Authors:  Yan-Hong Ni; Liang Ding; Xiao-Feng Huang; Ying-chun Dong; Qin-Gang Hu; Ya-Yi Hou
Journal:  Tumour Biol       Date:  2015-02-11

3.  Fucoidan reduced the invasion of oral squamous cell carcinoma cells and modified their effects to macrophages.

Authors:  Junda Lin; Ketao Wang; Huayang Wang; Qianqian Shao; Yijun Luan; Yan Xu; Xiaobin Song; Wanye Tan; Shaohua Liu; Fengcai Wei; Xun Qu
Journal:  Med Oncol       Date:  2016-12-21       Impact factor: 3.064

Review 4.  Engineering Vaccines to Reprogram Immunity against Head and Neck Cancer.

Authors:  Y S Tan; K Sansanaphongpricha; M E P Prince; D Sun; G T Wolf; Y L Lei
Journal:  J Dent Res       Date:  2018-03-13       Impact factor: 6.116

5.  Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity.

Authors:  Dayson Moreira; Sagus Sampath; Haejung Won; Seok Voon White; Yu-Lin Su; Marice Alcantara; Chongkai Wang; Peter Lee; Ellie Maghami; Erminia Massarelli; Marcin Kortylewski
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 6.  The role of transforming growth factor-beta in immune suppression and chronic inflammation of squamous cell carcinomas.

Authors:  Alexander A Strait; Xiao-Jing Wang
Journal:  Mol Carcinog       Date:  2020-04-17       Impact factor: 4.784

7.  White adipose tissue inflammation and cancer-specific survival in patients with squamous cell carcinoma of the oral tongue.

Authors:  Neil M Iyengar; Ronald A Ghossein; Luc G Morris; Xi K Zhou; Amit Kochhar; Patrick G Morris; David G Pfister; Snehal G Patel; Jay O Boyle; Clifford A Hudis; Andrew J Dannenberg
Journal:  Cancer       Date:  2016-08-10       Impact factor: 6.860

8.  Macrophages and endothelial cells orchestrate tumor-associated angiogenesis in oral cancer via hedgehog pathway activation.

Authors:  Ludmila de Faro Valverde; Thiago de Almeida Pereira; Rosane Borges Dias; Vanessa Sousa Nazaré Guimarães; Eduardo Antônio Gonçalves Ramos; Jean Nunes Santos; Clarissa Araújo Gurgel Rocha
Journal:  Tumour Biol       Date:  2016-01-15

Review 9.  Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer.

Authors:  Ruth J Davis; Carter Van Waes; Clint T Allen
Journal:  Oral Oncol       Date:  2016-05-20       Impact factor: 5.337

Review 10.  Tumor immune microenvironment in head and neck cancers.

Authors:  Samantha M Y Chen; Alexandra L Krinsky; Rachel A Woolaver; Xiaoguang Wang; Zhangguo Chen; Jing H Wang
Journal:  Mol Carcinog       Date:  2020-02-03       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.